Recall archive / FDA drug enforcement
rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheo... — FDA record D-0947-2023
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jul 14, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix, AZ, NDC 72196-6010-1.
- Reason
- Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
- Classification
- Class II
- Recalling firm
- Central Admixture Pharmacy Services, Inc.
- Quantity
- 77,554 Syringes.
- Agency-reported status
- Terminated
- Source record identifier
- D-0947-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot: 36-238805, 36-238806, 36-238808, 36-238809, 36-238810, 36-238811, Exp. 7/10/2023; 36-239229, 36-239319, 36-239320, 36-239321, 36-239322, Exp. 7/11/2023; 36-239453, 36-239454, 36-239455, Exp. 7/12/2023; 36-239851, 36-239852, Exp. 7/13/2023; 36-240204, Exp. 7/16/2023; 36-240509, 36-240510, 36-240511, Exp. 7/17/2023; 36-241263, 36-241266, Exp. 7/19/2023; 36-241362, 36-241363, 36-241365, Exp. 7/20/2023; 36-241880, 36-241881, 36-241882, Exp. 7/23/2023; 36-242376, 36-242377, Exp. 7/24/2023; 36-242603, 36-242618, Exp. 7/25/2023; 36-242643, 36-242644, 36-242645, Exp. 7/26/2023; 36-243534, 36-243535, Exp. 7/30/2023; 36-243831, Exp. 7/31/2023; 36-244831, 36-244833, 36-244841, 36-244842, 36-244845, 36-244855, Exp. 8/01/2023; 36-245803, Exp. 8/02/2023; 36-246288, 36-246289, 36-246290, 36-246291, 36-246369, Exp. 8/03/2023; 36-246775, 36-246776, 36-246777, 36-246778, 36-246779, Exp. 8/07/2023; 36-248327, Exp. 8/13/2023; 36-249504, 36-249505, Exp. 8/18/2023; 36-249685, 36-249686, 36-249687, Exp. 8/20/2023; 36-249746, 36-249748, 36-249749, 36-249751, 36-249752, 36-249753, Exp. 8/21/2023; 36-250070, 36-250071, Exp. 8/22/2023; 36-250416, 36-250417, 36-250418, 36-250419, 36-250420, 36-250421, Exp. 8/23/2023; 36-251027, 36-251028, Exp. 8/24/2023; 36-251566, 36-251567, 36-251568, Exp. 8/28/2023; 36-251772, 36-251773, 36-251774, 36-251775, Exp. 8/29/2023; 36-252323, Exp. 8/31/2023 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Nationwide in the USA
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Report date
- Aug 9, 2023
- Recall initiation date
- Jul 14, 2023
- Center classification date
- Aug 1, 2023
- Termination date
- Mar 28, 2025
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.